| Development of Novel Therapeutics to Raise HDL and Block Inflammation |
| |
| 引用本文： | DanielL.Sparks,NiharR.Pandey. Development of Novel Therapeutics to Raise HDL and Block Inflammation[J]. 中国动脉硬化杂志, 2009, 17(7): 575-576 |
| |
| 作者姓名： | DanielL.Sparks NiharR.Pandey |
| |
| 作者单位： | TheUniversityofOttawaHeartInstitute;TheUniversityofOttawaHeartInstitute |
| |
| 摘 要： | Plant derived phospholipids are rich in linoleic acid (LA) and have therapeutic value to treat inflammatory diseases of the liver,intestine and vasculature. These phospholipids act to normalize plasma lipid levels and prevent atherosclerotic disease. Oral administration of LA-phospholipids to cholesterol-fed rabbits prevents the development of atherosclerosis.
|
Development of Novel Therapeutics to Raise HDL and Block Inflammation |
| |
| Daniel L. Sparks,and Nihar R. Pandey. Development of Novel Therapeutics to Raise HDL and Block Inflammation[J]. Chinese Journal of Arteriosclerosis, 2009, 17(7): 575-576 |
| |
| Authors: | Daniel L. Sparks and Nihar R. Pandey |
| |
| Affiliation: | The University of Ottawa Heart Institute |
| |
| Abstract: | |
| |
| Keywords: | High Density Lipoproteini Dilinoleoyl Phosphatidylcholine |
|
| 点击此处可从《中国动脉硬化杂志》浏览原始摘要信息 |
|
点击此处可从《中国动脉硬化杂志》下载免费的PDF全文 |
